Christine M Friedenreich Selected Research

beta-Aminoethyl Isothiourea (AET)

1/2016	Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
1/2013	Patient satisfaction with participation in a randomized exercise trial: effects of randomization and a usual care posttrial exercise program.
6/2012	A randomized trial of aerobic exercise and sleep quality in lymphoma patients receiving chemotherapy or no treatments.
9/2009	Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients.
10/2008	Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial.
4/2008	Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
12/2007	Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine M Friedenreich Research Topics

Disease

61	Breast Neoplasms (Breast Cancer) 05/2022 - 04/2005
49	Neoplasms (Cancer) 01/2022 - 11/2002
17	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 04/2007
13	Insulin Resistance 01/2022 - 01/2009
12	Inflammation (Inflammations) 01/2022 - 01/2009
12	Obesity 01/2022 - 11/2002
8	Overweight 06/2020 - 01/2009
6	Fatigue 11/2021 - 10/2007
5	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2017
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2019
5	Lymphoma (Lymphomas) 10/2019 - 09/2009
4	Weight Loss (Weight Reduction) 01/2021 - 01/2009
4	Chronic Disease (Chronic Diseases) 01/2020 - 11/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2016
3	Hypertension (High Blood Pressure) 01/2020 - 11/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 11/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 01/2018
2	Hepatitis B 01/2019 - 07/2017
2	Carcinogenesis 01/2018 - 01/2018
2	Anemia 01/2016 - 10/2007
2	Lymphedema (Milroy Disease) 11/2012 - 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Death (Near-Death Experience) 11/2021
1	Stillbirth 01/2021
1	Disease Progression 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2005
22	Biological ProductsIBA 10/2021 - 11/2002
10	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2020 - 03/2010
10	Estrogens (Estrogen)FDA Link 12/2018 - 04/2005
9	Hormones (Hormone)IBA 01/2021 - 11/2002
7	beta-Aminoethyl Isothiourea (AET)IBA 01/2016 - 12/2007
6	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 03/2010
6	Estrone FDA Link 01/2021 - 01/2009
6	RadonIBA 08/2019 - 06/2017
5	Insulin (Novolin)FDA Link 01/2021 - 06/2011
5	Sex Hormone-Binding GlobulinIBA 01/2021 - 01/2009
5	C-Reactive ProteinIBA 12/2020 - 01/2009
4	CarcinogensIBA 01/2019 - 06/2017
4	Oral ContraceptivesIBA 07/2017 - 07/2013
4	AdipokinesIBA 06/2011 - 09/2010
3	AmberIBA 03/2022 - 11/2012
3	ORALIT (ORS)IBA 01/2021 - 04/2005
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2011
3	HDL CholesterolIBA 01/2021 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
3	Testosterone (Sustanon)FDA Link 02/2020 - 03/2010
3	CytokinesIBA 01/2019 - 07/2013
3	Vitamin D FDA LinkGeneric 07/2017 - 09/2010
3	LeptinIBA 12/2012 - 01/2009
3	AdiponectinIBA 12/2012 - 01/2009
2	CholesterolIBA 01/2021 - 11/2017
2	LipidsIBA 01/2021 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 01/2019
2	Capecitabine (Xeloda)FDA Link 10/2020 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 01/2019
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2019
2	Androstenedione (4 Androstene 3,17 dione)IBA 02/2020 - 03/2010
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 11/2011
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 11/2017
2	Particulate MatterIBA 01/2019 - 06/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 11/2002
2	Contraceptive Agents (Contraceptives)IBA 10/2016 - 03/2015
2	Estrogen ReceptorsIBA 10/2016 - 09/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2013 - 01/2009
2	Interleukin-6 (Interleukin 6)IBA 07/2013 - 01/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2012 - 11/2011
1	Dietary Fiber FDA Link 01/2022
1	SugarsIBA 01/2022
1	FructoseIBA 01/2022
1	FatsIBA 01/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	LDL CholesterolIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	CatalaseIBA 01/2021
1	SteroidsIBA 01/2021
1	Superoxide DismutaseIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2021
1	Glutathione PeroxidaseIBA 01/2021
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	EnzymesIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 12/2020

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 07/2021 - 10/2007
19	Therapeutics 10/2021 - 06/2003
14	Adjuvant Chemotherapy 07/2021 - 10/2007
5	Wearable Electronic Devices 01/2021 - 01/2018
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2016 - 04/2005
2	Resistance Training 07/2021 - 09/2014
2	Fitness Trackers 01/2021 - 01/2019
2	Aftercare (After-Treatment) 06/2015 - 11/2012
1	Treatment Delay 05/2022
1	Tai Ji (Tai Chi Chuan) 11/2021
1	Continuity of Patient Care 11/2021
1	Induced Abortion (Induced Abortions) 01/2021